R&D
Partner Content
2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit
2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit re
Views & Analysis
R&D
Sponsored
Trials and tribulations of drug development
What does it take to establish new treatments for rare diseases?
R&D
Into the bowels of gut research
For people living with Inflammatory Bowel Disease (IBD), navigating life around the risk of flare-ups can be a messy and exhausting challenge.
Sales & Marketing
Sponsored
Empowering MSLs to be the kings of Pharma’s New Frontier
The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector. But, al
Digital
Sponsored
Artificial intelligence in medicine
Thanks to constant advances in technology and science, artificial intelligence (AI) is rapidly becoming an integral part of modern healthcare.
R&D
Partner Content
Novel Nasal Formulation & Delivery Summit
Not only has the pandemic fuelled interest in new modalities research, but it has also triggered a renaissance of formulation approaches amongst biopharma to bring new wave of drug substances and t
R&D
Partner Content
2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy S...
Exciting results are expected this year, from multiple mid and late stage clinical trials and involving a broad array of adenosine drugs including CD73, CD39 and A2AR!
Category :
Views & Analysis
/
